{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:13:43Z","timestamp":1764782023099},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00216-014-7796-6","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T10:04:47Z","timestamp":1400061887000},"page":"3815-3829","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["GC-MS and LC-(high-resolution)-MS n studies on the metabolic fate and detectability of camfetamine in rat urine"],"prefix":"10.1007","volume":"406","author":[{"given":"Jessica","family":"Welter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierce","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"7796_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0306-3623(84)90039-9","volume":"15","author":"R DeLucia","year":"1984","unstructured":"DeLucia R, Bernardi MM, Scavone C, Aizenstein ML (1984) On the mechanism of central stimulation action of fencamfamine. Gen Pharmacol 15:407\u2013410","journal-title":"Gen Pharmacol"},{"key":"7796_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0306-3623(87)90163-7","volume":"18","author":"R DeLucia","year":"1987","unstructured":"DeLucia R, Planeta CS, Scavone C, Aizenstein ML (1987) Reduction of food intake by fencamfamine in rats. Gen Pharmacol 18:21\u201323","journal-title":"Gen Pharmacol"},{"key":"7796_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-3623(87)90089-9","volume":"18","author":"CS Planeta","year":"1987","unstructured":"Planeta CS, Scavone C, De LR, Aizenstein ML (1987) Behavioural effects of long-term administration of fencamfamine: neurochemical implications. Gen Pharmacol 18:347\u2013349","journal-title":"Gen Pharmacol"},{"key":"7796_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/07420528909056937","volume":"6","author":"CS Planeta","year":"1989","unstructured":"Planeta CS, Aizenstein ML, Scavone C, DeLucia R (1989) Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach. Chronobiol Int 6:313\u2013320","journal-title":"Chronobiol Int"},{"key":"7796_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0091-3057(94)00236-C","volume":"50","author":"CS Planeta","year":"1995","unstructured":"Planeta CS, Aizenstein ML, DeLucia R (1995) Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors. Pharmacol Biochem Behav 50:35\u201340","journal-title":"Pharmacol Biochem Behav"},{"key":"7796_CR6","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1523\/JNEUROSCI.11-09-02703.1991","volume":"11","author":"R Kuczenski","year":"1991","unstructured":"Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703\u20132712","journal-title":"J Neurosci"},{"key":"7796_CR7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0731-7085(92)80093-3","volume":"10","author":"FT Delbeke","year":"1992","unstructured":"Delbeke FT, Debackere M (1992) Disposition of human drug preparations in the horse. II. Orally administered fencamfamine. J Pharm Biomed Anal 10:651\u2013656","journal-title":"J Pharm Biomed Anal"},{"key":"7796_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/bdd.2510020103","volume":"2","author":"FT Delbeke","year":"1981","unstructured":"Delbeke FT, Debackere M (1981) Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion. Biopharm Drug Dispos 2:17\u201330","journal-title":"Biopharm Drug Dispos"},{"key":"7796_CR9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/dta.411","volume":"5","author":"P Kavanagh","year":"2013","unstructured":"Kavanagh P, Angelov D, O'Brien J, Power JD, McDermott SD, Talbot B, Fox J, O'Donnell C, Christie R (2013) The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine). Drug Test Anal 5:247\u2013253","journal-title":"Drug Test Anal"},{"key":"7796_CR10","volume-title":"Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites","author":"HH Maurer","year":"2011","unstructured":"Maurer HH, Pfleger K, Weber AA (2011) Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites. Wiley-VCH, Weinheim"},{"key":"7796_CR11","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00216-013-6741-4","volume":"405","author":"J Welter","year":"2013","unstructured":"Welter J, Meyer MR, Wolf E, Weinmann W, Kavanagh P, Maurer HH (2013) 2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques. Anal Bioanal Chem 405:3125\u20133135","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00216-013-7595-5","volume":"406","author":"J Welter","year":"2014","unstructured":"Welter J, Meyer MR, Kavanagh P, Maurer HH (2014) Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn. Anal Bioanal Chem 406:1957\u20131974","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jms.3112","volume":"48","author":"GMJ Meyer","year":"2013","unstructured":"Meyer GMJ, Meyer MR, Wissenbach DK, Maurer HH (2013) Studies on the metabolism and toxicological detection of glaucine, an isoquinoline alkaloid from Glaucium flavum (Papaveraceae), in rat urine using GC-MS, LC-MSn and LC-high-resolution MSn. J Mass Spectrom 48:24\u201341","journal-title":"J Mass Spectrom"},{"key":"7796_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jms.3142","volume":"48","author":"MR Meyer","year":"2013","unstructured":"Meyer MR, Schmitt S, Maurer HH (2013) Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS\/MS. J Mass Spectrom 48:243\u2013249","journal-title":"J Mass Spectrom"},{"key":"7796_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00216-010-4398-9","volume":"400","author":"DK Wissenbach","year":"2011","unstructured":"Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC-MSn urine drug screening procedure\u2014exemplified for antidepressants. Anal Bioanal Chem 400:79\u201388","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR16","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1007\/s00216-011-5032-1","volume":"400","author":"DK Wissenbach","year":"2011","unstructured":"Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400:3481\u20133489","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR17","volume-title":"Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants, and their Metabolites","author":"HH Maurer","year":"2011","unstructured":"Maurer HH, Pfleger K, Weber AA (2011) Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants, and their Metabolites. Wiley-VCH, Weinheim"},{"key":"7796_CR18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00216-008-1917-z","volume":"390","author":"AH Ewald","year":"2008","unstructured":"Ewald AH, Ehlers D, Maurer HH (2008) Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 390:1837\u20131842","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1373\/clinchem.2009.135517","volume":"56","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Peters FT, Maurer HH (2010) Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 56:575\u2013584","journal-title":"Clin Chem"},{"key":"7796_CR20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","volume":"397","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397:1225\u20131233","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR21","volume-title":"Interpretation of Mass Spectra","author":"FW McLafferty","year":"1993","unstructured":"McLafferty FW, Turecek F (1993) Interpretation of Mass Spectra. University Science Books, Mill Valley"},{"key":"7796_CR22","volume-title":"Understanding Mass Spectra\u2014A Basic Approach","author":"RM Smith","year":"1999","unstructured":"Smith RM, Busch KL (1999) Understanding Mass Spectra\u2014A Basic Approach. Wiley, New York"},{"key":"7796_CR23","volume-title":"Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG commission for clinical toxicological analysis, special issue of the TIAFT bulletin)","author":"RA de-Zeeuw","year":"1992","unstructured":"de-Zeeuw RA, Franke JP, Maurer HH, Pfleger K (1992) Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG commission for clinical toxicological analysis, special issue of the TIAFT bulletin). VCH Publishers, Weinheim"},{"key":"7796_CR24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hlca.19580410703","volume":"41","author":"E Kovats","year":"1958","unstructured":"Kovats E (1958) Gaschromatographische Charakterisierung organischer Verbindungen. Teil 1. Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde, und Ketone. Helv Chim Acta 41:1915\u20131932","journal-title":"Helv Chim Acta"},{"key":"7796_CR25","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1007\/s00216-013-7051-6","volume":"405","author":"MR Meyer","year":"2013","unstructured":"Meyer MR, Bach M, Welter J, Bovens M, Turcant A, Maurer HH (2013) Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. Anal Bioanal Chem 405:6307\u20136321","journal-title":"Anal Bioanal Chem"},{"key":"7796_CR26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH (2009) To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol 157:907\u2013921","journal-title":"Br J Pharmacol"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-7796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-014-7796-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-7796-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T12:44:48Z","timestamp":1565441088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-014-7796-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":26,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["7796"],"URL":"https:\/\/doi.org\/10.1007\/s00216-014-7796-6","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}